als, 1 month ago Providers are told not to prescribe or to stop prescribing puberty blockers or gender-affirming hormones. They are also told that if the trans child or young person and/or their family “disregards your advice and you consider that this puts the child/young person at increased risk, then a safeguarding referral may also be appropriate in line with standard safeguarding approaches.”
Providers are told not to prescribe or to stop prescribing puberty blockers or gender-affirming hormones. They are also told that if the trans child or young person and/or their family “disregards your advice and you consider that this puts the child/young person at increased risk, then a safeguarding referral may also be appropriate in line with standard safeguarding approaches.”